GO:0009570 | chloroplast stroma | 35.06% (27/77) | 4.04 | 0.0 | 0.0 |
GO:0009532 | plastid stroma | 35.06% (27/77) | 4.04 | 0.0 | 0.0 |
GO:0009507 | chloroplast | 58.44% (45/77) | 2.11 | 0.0 | 0.0 |
GO:0009536 | plastid | 58.44% (45/77) | 2.08 | 0.0 | 0.0 |
GO:0090079 | translation regulator activity, nucleic acid binding | 16.88% (13/77) | 5.23 | 0.0 | 0.0 |
GO:0045182 | translation regulator activity | 16.88% (13/77) | 5.21 | 0.0 | 0.0 |
GO:0008135 | translation factor activity, RNA binding | 16.88% (13/77) | 5.25 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 58.44% (45/77) | 1.66 | 0.0 | 0.0 |
GO:0006164 | purine nucleotide biosynthetic process | 12.99% (10/77) | 5.52 | 0.0 | 0.0 |
GO:0072522 | purine-containing compound biosynthetic process | 12.99% (10/77) | 5.35 | 0.0 | 0.0 |
GO:1901566 | organonitrogen compound biosynthetic process | 31.17% (24/77) | 2.61 | 0.0 | 0.0 |
GO:0044281 | small molecule metabolic process | 40.26% (31/77) | 2.08 | 0.0 | 0.0 |
GO:1901293 | nucleoside phosphate biosynthetic process | 16.88% (13/77) | 4.05 | 0.0 | 0.0 |
GO:0009165 | nucleotide biosynthetic process | 16.88% (13/77) | 4.06 | 0.0 | 0.0 |
GO:0003746 | translation elongation factor activity | 9.09% (7/77) | 6.49 | 0.0 | 0.0 |
GO:1901564 | organonitrogen compound metabolic process | 48.05% (37/77) | 1.74 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 37.66% (29/77) | 2.12 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 41.56% (32/77) | 1.95 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 40.26% (31/77) | 2.0 | 0.0 | 0.0 |
GO:0006520 | cellular amino acid metabolic process | 20.78% (16/77) | 3.22 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 58.44% (45/77) | 1.35 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 62.34% (48/77) | 1.24 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 18.18% (14/77) | 3.29 | 0.0 | 0.0 |
GO:1901576 | organic substance biosynthetic process | 44.16% (34/77) | 1.65 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 63.64% (49/77) | 1.15 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 59.74% (46/77) | 1.24 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 40.26% (31/77) | 1.77 | 0.0 | 0.0 |
GO:0009058 | biosynthetic process | 44.16% (34/77) | 1.6 | 0.0 | 0.0 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 19.48% (15/77) | 3.01 | 0.0 | 0.0 |
GO:0009117 | nucleotide metabolic process | 18.18% (14/77) | 3.09 | 0.0 | 0.0 |
GO:0006753 | nucleoside phosphate metabolic process | 18.18% (14/77) | 3.09 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 37.66% (29/77) | 1.75 | 0.0 | 0.0 |
GO:0016874 | ligase activity | 11.69% (9/77) | 4.15 | 0.0 | 0.0 |
GO:0006163 | purine nucleotide metabolic process | 14.29% (11/77) | 3.51 | 0.0 | 0.0 |
GO:0009089 | lysine biosynthetic process via diaminopimelate | 5.19% (4/77) | 7.49 | 0.0 | 0.0 |
GO:0046451 | diaminopimelate metabolic process | 5.19% (4/77) | 7.49 | 0.0 | 0.0 |
GO:0009085 | lysine biosynthetic process | 5.19% (4/77) | 7.49 | 0.0 | 0.0 |
GO:0044249 | cellular biosynthetic process | 38.96% (30/77) | 1.62 | 0.0 | 0.0 |
GO:0072521 | purine-containing compound metabolic process | 14.29% (11/77) | 3.42 | 0.0 | 0.0 |
GO:0006553 | lysine metabolic process | 5.19% (4/77) | 7.32 | 0.0 | 0.0 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 16.88% (13/77) | 2.94 | 0.0 | 0.0 |
GO:0090407 | organophosphate biosynthetic process | 18.18% (14/77) | 2.78 | 0.0 | 0.0 |
GO:0009987 | cellular process | 67.53% (52/77) | 0.89 | 0.0 | 1e-06 |
GO:0003824 | catalytic activity | 53.25% (41/77) | 1.14 | 0.0 | 1e-06 |
GO:0018130 | heterocycle biosynthetic process | 19.48% (15/77) | 2.47 | 0.0 | 1e-06 |
GO:0140101 | catalytic activity, acting on a tRNA | 7.79% (6/77) | 4.83 | 0.0 | 1e-06 |
GO:0019637 | organophosphate metabolic process | 20.78% (16/77) | 2.33 | 0.0 | 2e-06 |
GO:0005739 | mitochondrion | 35.06% (27/77) | 1.56 | 0.0 | 2e-06 |
GO:0019752 | carboxylic acid metabolic process | 24.68% (19/77) | 1.98 | 0.0 | 3e-06 |
GO:0004812 | aminoacyl-tRNA ligase activity | 6.49% (5/77) | 5.26 | 0.0 | 3e-06 |
GO:0043038 | amino acid activation | 6.49% (5/77) | 5.26 | 0.0 | 3e-06 |
GO:0043039 | tRNA aminoacylation | 6.49% (5/77) | 5.26 | 0.0 | 3e-06 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 6.49% (5/77) | 5.26 | 0.0 | 3e-06 |
GO:0006418 | tRNA aminoacylation for protein translation | 6.49% (5/77) | 5.26 | 0.0 | 3e-06 |
GO:0043227 | membrane-bounded organelle | 87.01% (67/77) | 0.53 | 0.0 | 3e-06 |
GO:0043231 | intracellular membrane-bounded organelle | 87.01% (67/77) | 0.54 | 0.0 | 4e-06 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 20.78% (16/77) | 2.22 | 0.0 | 4e-06 |
GO:0043229 | intracellular organelle | 87.01% (67/77) | 0.52 | 0.0 | 6e-06 |
GO:0005622 | intracellular anatomical structure | 87.01% (67/77) | 0.52 | 0.0 | 6e-06 |
GO:0043226 | organelle | 87.01% (67/77) | 0.52 | 0.0 | 6e-06 |
GO:0044283 | small molecule biosynthetic process | 20.78% (16/77) | 2.17 | 0.0 | 6e-06 |
GO:0006094 | gluconeogenesis | 9.09% (7/77) | 3.94 | 0.0 | 6e-06 |
GO:0019319 | hexose biosynthetic process | 9.09% (7/77) | 3.91 | 0.0 | 6e-06 |
GO:0043436 | oxoacid metabolic process | 24.68% (19/77) | 1.9 | 0.0 | 6e-06 |
GO:0006796 | phosphate-containing compound metabolic process | 23.38% (18/77) | 1.97 | 0.0 | 7e-06 |
GO:0006399 | tRNA metabolic process | 7.79% (6/77) | 4.33 | 1e-06 | 8e-06 |
GO:0006006 | glucose metabolic process | 10.39% (8/77) | 3.49 | 1e-06 | 8e-06 |
GO:0006793 | phosphorus metabolic process | 23.38% (18/77) | 1.95 | 1e-06 | 8e-06 |
GO:0046364 | monosaccharide biosynthetic process | 9.09% (7/77) | 3.8 | 1e-06 | 1e-05 |
GO:0006082 | organic acid metabolic process | 24.68% (19/77) | 1.85 | 1e-06 | 1e-05 |
GO:0019318 | hexose metabolic process | 10.39% (8/77) | 3.36 | 1e-06 | 1.5e-05 |
GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor | 3.9% (3/77) | 6.75 | 2e-06 | 3.2e-05 |
GO:0043648 | dicarboxylic acid metabolic process | 5.19% (4/77) | 5.36 | 3e-06 | 3.5e-05 |
GO:0005996 | monosaccharide metabolic process | 10.39% (8/77) | 3.13 | 4e-06 | 4.7e-05 |
GO:0008836 | diaminopimelate decarboxylase activity | 2.6% (2/77) | 8.49 | 8e-06 | 9e-05 |
GO:0004820 | glycine-tRNA ligase activity | 2.6% (2/77) | 8.49 | 8e-06 | 9e-05 |
GO:0006426 | glycyl-tRNA aminoacylation | 2.6% (2/77) | 8.49 | 8e-06 | 9e-05 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 2.6% (2/77) | 8.49 | 8e-06 | 9e-05 |
GO:0005951 | carbamoyl-phosphate synthase complex | 2.6% (2/77) | 8.49 | 8e-06 | 9e-05 |
GO:0090304 | nucleic acid metabolic process | 22.08% (17/77) | 1.73 | 1e-05 | 0.000118 |
GO:0009260 | ribonucleotide biosynthetic process | 7.79% (6/77) | 3.6 | 1.1e-05 | 0.00012 |
GO:0046390 | ribose phosphate biosynthetic process | 7.79% (6/77) | 3.6 | 1.1e-05 | 0.00012 |
GO:1901362 | organic cyclic compound biosynthetic process | 19.48% (15/77) | 1.87 | 1.1e-05 | 0.000127 |
GO:0016829 | lyase activity | 9.09% (7/77) | 3.19 | 1.2e-05 | 0.000134 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 5.19% (4/77) | 4.79 | 1.4e-05 | 0.000149 |
GO:0008652 | cellular amino acid biosynthetic process | 10.39% (8/77) | 2.83 | 1.7e-05 | 0.000183 |
GO:0016831 | carboxy-lyase activity | 5.19% (4/77) | 4.63 | 2.1e-05 | 0.000225 |
GO:0009218 | pyrimidine ribonucleotide metabolic process | 6.49% (5/77) | 3.76 | 3.6e-05 | 0.000361 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 6.49% (5/77) | 3.76 | 3.6e-05 | 0.000361 |
GO:0019693 | ribose phosphate metabolic process | 10.39% (8/77) | 2.68 | 3.5e-05 | 0.000363 |
GO:0009259 | ribonucleotide metabolic process | 10.39% (8/77) | 2.68 | 3.5e-05 | 0.000363 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 6.49% (5/77) | 3.74 | 3.7e-05 | 0.000366 |
GO:0006220 | pyrimidine nucleotide metabolic process | 6.49% (5/77) | 3.74 | 3.7e-05 | 0.000366 |
GO:0019438 | aromatic compound biosynthetic process | 16.88% (13/77) | 1.91 | 3.6e-05 | 0.000368 |
GO:0140098 | catalytic activity, acting on RNA | 7.79% (6/77) | 3.24 | 4.3e-05 | 0.000419 |
GO:0009066 | aspartate family amino acid metabolic process | 6.49% (5/77) | 3.69 | 4.4e-05 | 0.000427 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 6.49% (5/77) | 3.68 | 4.6e-05 | 0.000437 |
GO:0046686 | response to cadmium ion | 10.39% (8/77) | 2.62 | 4.9e-05 | 0.000458 |
GO:0048229 | gametophyte development | 7.79% (6/77) | 3.21 | 4.8e-05 | 0.000458 |
GO:1901135 | carbohydrate derivative metabolic process | 15.58% (12/77) | 1.97 | 5e-05 | 0.000464 |
GO:1901137 | carbohydrate derivative biosynthetic process | 10.39% (8/77) | 2.56 | 6.3e-05 | 0.000584 |
GO:0072527 | pyrimidine-containing compound metabolic process | 6.49% (5/77) | 3.55 | 7e-05 | 0.000634 |
GO:0007010 | cytoskeleton organization | 9.09% (7/77) | 2.78 | 7.2e-05 | 0.000641 |
GO:0003743 | translation initiation factor activity | 5.19% (4/77) | 4.18 | 7.1e-05 | 0.000643 |
GO:0009082 | branched-chain amino acid biosynthetic process | 2.6% (2/77) | 7.17 | 7.6e-05 | 0.000674 |
GO:0016051 | carbohydrate biosynthetic process | 12.99% (10/77) | 2.12 | 9.9e-05 | 0.00087 |
GO:0009081 | branched-chain amino acid metabolic process | 2.6% (2/77) | 6.9 | 0.000114 | 0.00099 |
GO:0016830 | carbon-carbon lyase activity | 5.19% (4/77) | 3.93 | 0.00014 | 0.001206 |
GO:0042727 | flavin-containing compound biosynthetic process | 2.6% (2/77) | 6.68 | 0.000159 | 0.001322 |
GO:0006771 | riboflavin metabolic process | 2.6% (2/77) | 6.68 | 0.000159 | 0.001322 |
GO:0009231 | riboflavin biosynthetic process | 2.6% (2/77) | 6.68 | 0.000159 | 0.001322 |
GO:0009555 | pollen development | 6.49% (5/77) | 3.3 | 0.000157 | 0.001342 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 2.6% (2/77) | 6.49 | 0.000212 | 0.001699 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 2.6% (2/77) | 6.49 | 0.000212 | 0.001699 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 2.6% (2/77) | 6.49 | 0.000212 | 0.001699 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 2.6% (2/77) | 6.49 | 0.000212 | 0.001699 |
GO:0005829 | cytosol | 16.88% (13/77) | 1.65 | 0.000225 | 0.001787 |
GO:0010038 | response to metal ion | 10.39% (8/77) | 2.28 | 0.000236 | 0.001864 |
GO:0005507 | copper ion binding | 6.49% (5/77) | 3.16 | 0.000249 | 0.001949 |
GO:0042726 | flavin-containing compound metabolic process | 2.6% (2/77) | 6.32 | 0.000272 | 0.002108 |
GO:0010498 | proteasomal protein catabolic process | 6.49% (5/77) | 3.11 | 0.000292 | 0.002245 |
GO:0009067 | aspartate family amino acid biosynthetic process | 5.19% (4/77) | 3.63 | 0.000314 | 0.002394 |
GO:1901363 | heterocyclic compound binding | 24.68% (19/77) | 1.22 | 0.000323 | 0.002443 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 2.6% (2/77) | 6.17 | 0.000339 | 0.002485 |
GO:0006547 | histidine metabolic process | 2.6% (2/77) | 6.17 | 0.000339 | 0.002485 |
GO:0000105 | histidine biosynthetic process | 2.6% (2/77) | 6.17 | 0.000339 | 0.002485 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 2.6% (2/77) | 6.17 | 0.000339 | 0.002485 |
GO:0097159 | organic cyclic compound binding | 24.68% (19/77) | 1.22 | 0.000351 | 0.00255 |
GO:0006996 | organelle organization | 15.58% (12/77) | 1.67 | 0.000355 | 0.002556 |
GO:0034660 | ncRNA metabolic process | 7.79% (6/77) | 2.65 | 0.000394 | 0.002819 |
GO:0009123 | nucleoside monophosphate metabolic process | 2.6% (2/77) | 6.03 | 0.000414 | 0.002831 |
GO:0003747 | translation release factor activity | 2.6% (2/77) | 6.03 | 0.000414 | 0.002831 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 2.6% (2/77) | 6.03 | 0.000414 | 0.002831 |
GO:0008079 | translation termination factor activity | 2.6% (2/77) | 6.03 | 0.000414 | 0.002831 |
GO:0006415 | translational termination | 2.6% (2/77) | 6.03 | 0.000414 | 0.002831 |
GO:0016070 | RNA metabolic process | 15.58% (12/77) | 1.64 | 0.000423 | 0.002874 |
GO:0043170 | macromolecule metabolic process | 32.47% (25/77) | 0.98 | 0.00041 | 0.00291 |
GO:0016053 | organic acid biosynthetic process | 12.99% (10/77) | 1.85 | 0.000439 | 0.00296 |
GO:1901605 | alpha-amino acid metabolic process | 9.09% (7/77) | 2.34 | 0.000466 | 0.003119 |
GO:0008252 | nucleotidase activity | 2.6% (2/77) | 5.9 | 0.000496 | 0.003295 |
GO:0006310 | DNA recombination | 6.49% (5/77) | 2.92 | 0.00053 | 0.003496 |
GO:1901607 | alpha-amino acid biosynthetic process | 7.79% (6/77) | 2.56 | 0.000555 | 0.003633 |
GO:0043167 | ion binding | 16.88% (13/77) | 1.51 | 0.000576 | 0.003747 |
GO:0032984 | protein-containing complex disassembly | 2.6% (2/77) | 5.79 | 0.000585 | 0.003753 |
GO:0043624 | cellular protein complex disassembly | 2.6% (2/77) | 5.79 | 0.000585 | 0.003753 |
GO:0030163 | protein catabolic process | 6.49% (5/77) | 2.86 | 0.000639 | 0.00407 |
GO:0005488 | binding | 37.66% (29/77) | 0.84 | 0.00065 | 0.004113 |
GO:0003676 | nucleic acid binding | 19.48% (15/77) | 1.35 | 0.000661 | 0.004151 |
GO:0016742 | hydroxymethyl-, formyl- and related transferase activity | 2.6% (2/77) | 5.68 | 0.000681 | 0.004225 |
GO:1900864 | mitochondrial RNA modification | 2.6% (2/77) | 5.68 | 0.000681 | 0.004225 |
GO:0007275 | multicellular organism development | 11.69% (9/77) | 1.88 | 0.000724 | 0.00446 |
GO:0009941 | chloroplast envelope | 9.09% (7/77) | 2.23 | 0.000737 | 0.004509 |
GO:0009526 | plastid envelope | 9.09% (7/77) | 2.22 | 0.000778 | 0.004698 |
GO:0000959 | mitochondrial RNA metabolic process | 2.6% (2/77) | 5.58 | 0.000785 | 0.004709 |
GO:0003674 | molecular_function | 88.31% (68/77) | 0.28 | 0.000791 | 0.004714 |
GO:0005975 | carbohydrate metabolic process | 14.29% (11/77) | 1.63 | 0.000778 | 0.004727 |
GO:0031975 | envelope | 9.09% (7/77) | 2.06 | 0.001442 | 0.008489 |
GO:0031967 | organelle envelope | 9.09% (7/77) | 2.06 | 0.001442 | 0.008489 |
GO:0007129 | homologous chromosome pairing at meiosis | 3.9% (3/77) | 3.75 | 0.001462 | 0.008549 |
GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 2.6% (2/77) | 5.1 | 0.001553 | 0.009025 |
GO:0070192 | chromosome organization involved in meiotic cell cycle | 3.9% (3/77) | 3.7 | 0.001625 | 0.009386 |
GO:0016840 | carbon-nitrogen lyase activity | 2.6% (2/77) | 5.03 | 0.001705 | 0.009787 |
GO:0048046 | apoplast | 6.49% (5/77) | 2.45 | 0.002239 | 0.012776 |
GO:0000107 | imidazoleglycerol-phosphate synthase activity | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0004399 | histidinol dehydrogenase activity | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0000906 | 6,7-dimethyl-8-ribityllumazine synthase activity | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0004401 | histidinol-phosphatase activity | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0003937 | IMP cyclohydrolase activity | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0010285 | L,L-diaminopimelate aminotransferase activity | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0004056 | argininosuccinate lyase activity | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0046033 | AMP metabolic process | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0004019 | adenylosuccinate synthase activity | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0090174 | organelle membrane fusion | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0030929 | ADPG pyrophosphorylase complex | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0030931 | heterotetrameric ADPG pyrophosphorylase complex | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0052096 | formation of syncytium involving giant cell for nutrient acquisition | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0004073 | aspartate-semialdehyde dehydrogenase activity | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0052093 | formation of specialized structure for nutrient acquisition | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0004642 | phosphoribosylformylglycinamidine synthase activity | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0004643 | phosphoribosylaminoimidazolecarboxamide formyltransferase activity | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0044115 | development of symbiont involved in interaction with host | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0090471 | 9,15,9'-tri-cis-zeta-carotene isomerase activity | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0044111 | development involved in symbiotic interaction | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0018444 | translation release factor complex | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0061025 | membrane fusion | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0000740 | nuclear membrane fusion | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0004455 | ketol-acid reductoisomerase activity | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0009097 | isoleucine biosynthetic process | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0006167 | AMP biosynthetic process | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0008835 | diaminohydroxyphosphoribosylaminopyrimidine deaminase activity | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0006549 | isoleucine metabolic process | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0004794 | L-threonine ammonia-lyase activity | 1.3% (1/77) | 8.49 | 0.002784 | 0.013417 |
GO:0022411 | cellular component disassembly | 2.6% (2/77) | 4.63 | 0.002959 | 0.014184 |
GO:0051276 | chromosome organization | 6.49% (5/77) | 2.41 | 0.002517 | 0.014272 |
GO:0016592 | mediator complex | 2.6% (2/77) | 4.58 | 0.003165 | 0.015093 |
GO:0046394 | carboxylic acid biosynthetic process | 10.39% (8/77) | 1.67 | 0.003613 | 0.017145 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.9% (3/77) | 3.22 | 0.004198 | 0.019816 |
GO:0032991 | protein-containing complex | 12.99% (10/77) | 1.4 | 0.004312 | 0.020255 |
GO:0016043 | cellular component organization | 19.48% (15/77) | 1.06 | 0.004626 | 0.02151 |
GO:0006259 | DNA metabolic process | 7.79% (6/77) | 1.95 | 0.004607 | 0.02153 |
GO:0034401 | chromatin organization involved in regulation of transcription | 5.19% (4/77) | 2.56 | 0.004767 | 0.021945 |
GO:0097549 | chromatin organization involved in negative regulation of transcription | 5.19% (4/77) | 2.56 | 0.004767 | 0.021945 |
GO:0004814 | arginine-tRNA ligase activity | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0006420 | arginyl-tRNA aminoacylation | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0008840 | 4-hydroxy-tetrahydrodipicolinate synthase activity | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0004821 | histidine-tRNA ligase activity | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0006427 | histidyl-tRNA aminoacylation | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0009378 | four-way junction helicase activity | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0070456 | galactose-1-phosphate phosphatase activity | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0001682 | tRNA 5'-leader removal | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0004638 | phosphoribosylaminoimidazole carboxylase activity | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0051085 | chaperone cofactor-dependent protein refolding | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0017151 | DEAD/H-box RNA helicase binding | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0006458 | 'de novo' protein folding | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0099116 | tRNA 5'-end processing | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0010347 | L-galactose-1-phosphate phosphatase activity | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0010198 | synergid death | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0006189 | 'de novo' IMP biosynthetic process | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0016074 | sno(s)RNA metabolic process | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0034471 | ncRNA 5'-end processing | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0043144 | sno(s)RNA processing | 1.3% (1/77) | 7.49 | 0.005561 | 0.023296 |
GO:0110165 | cellular anatomical entity | 94.81% (73/77) | 0.16 | 0.00572 | 0.023855 |
GO:0042364 | water-soluble vitamin biosynthetic process | 2.6% (2/77) | 4.13 | 0.005849 | 0.024282 |
GO:0008150 | biological_process | 87.01% (67/77) | 0.22 | 0.005916 | 0.024451 |
GO:0016036 | cellular response to phosphate starvation | 3.9% (3/77) | 3.03 | 0.006011 | 0.024736 |
GO:0006767 | water-soluble vitamin metabolic process | 2.6% (2/77) | 4.06 | 0.006417 | 0.026062 |
GO:0016763 | transferase activity, transferring pentosyl groups | 2.6% (2/77) | 4.06 | 0.006417 | 0.026062 |
GO:0140527 | reciprocal homologous recombination | 3.9% (3/77) | 2.99 | 0.006527 | 0.026277 |
GO:0007131 | reciprocal meiotic recombination | 3.9% (3/77) | 2.99 | 0.006527 | 0.026277 |
GO:0035639 | purine ribonucleoside triphosphate binding | 7.79% (6/77) | 1.85 | 0.006414 | 0.026277 |
GO:0046914 | transition metal ion binding | 9.09% (7/77) | 1.66 | 0.00675 | 0.027058 |
GO:0035825 | homologous recombination | 3.9% (3/77) | 2.96 | 0.006794 | 0.027119 |
GO:0010564 | regulation of cell cycle process | 3.9% (3/77) | 2.95 | 0.00693 | 0.027544 |
GO:0017076 | purine nucleotide binding | 7.79% (6/77) | 1.82 | 0.007099 | 0.027741 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 6.49% (5/77) | 2.06 | 0.007088 | 0.027813 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3.9% (3/77) | 2.94 | 0.007068 | 0.027853 |
GO:0032555 | purine ribonucleotide binding | 7.79% (6/77) | 1.82 | 0.007045 | 0.027879 |
GO:0051225 | spindle assembly | 2.6% (2/77) | 3.96 | 0.007316 | 0.02835 |
GO:0009152 | purine ribonucleotide biosynthetic process | 2.6% (2/77) | 3.96 | 0.007316 | 0.02835 |
GO:0032553 | ribonucleotide binding | 7.79% (6/77) | 1.81 | 0.007376 | 0.028465 |
GO:0005524 | ATP binding | 6.49% (5/77) | 2.03 | 0.007785 | 0.029919 |
GO:0006435 | threonyl-tRNA aminoacylation | 1.3% (1/77) | 6.9 | 0.00833 | 0.030261 |
GO:0008934 | inositol monophosphate 1-phosphatase activity | 1.3% (1/77) | 6.9 | 0.00833 | 0.030261 |
GO:0000966 | RNA 5'-end processing | 1.3% (1/77) | 6.9 | 0.00833 | 0.030261 |
GO:0008253 | 5'-nucleotidase activity | 1.3% (1/77) | 6.9 | 0.00833 | 0.030261 |
GO:0016842 | amidine-lyase activity | 1.3% (1/77) | 6.9 | 0.00833 | 0.030261 |
GO:0046040 | IMP metabolic process | 1.3% (1/77) | 6.9 | 0.00833 | 0.030261 |
GO:0003862 | 3-isopropylmalate dehydrogenase activity | 1.3% (1/77) | 6.9 | 0.00833 | 0.030261 |
GO:0052834 | inositol monophosphate phosphatase activity | 1.3% (1/77) | 6.9 | 0.00833 | 0.030261 |
GO:0004829 | threonine-tRNA ligase activity | 1.3% (1/77) | 6.9 | 0.00833 | 0.030261 |
GO:0006188 | IMP biosynthetic process | 1.3% (1/77) | 6.9 | 0.00833 | 0.030261 |
GO:0097367 | carbohydrate derivative binding | 7.79% (6/77) | 1.79 | 0.007955 | 0.030319 |
GO:0007051 | spindle organization | 2.6% (2/77) | 3.9 | 0.007945 | 0.030407 |
GO:0005730 | nucleolus | 5.19% (4/77) | 2.32 | 0.008599 | 0.031116 |
GO:0030554 | adenyl nucleotide binding | 6.49% (5/77) | 1.99 | 0.008684 | 0.031181 |
GO:0032559 | adenyl ribonucleotide binding | 6.49% (5/77) | 1.99 | 0.008684 | 0.031181 |
GO:0070925 | organelle assembly | 2.6% (2/77) | 3.87 | 0.008268 | 0.031258 |
GO:0009110 | vitamin biosynthetic process | 2.6% (2/77) | 3.87 | 0.008268 | 0.031258 |
GO:0051726 | regulation of cell cycle | 5.19% (4/77) | 2.3 | 0.009014 | 0.032242 |
GO:1901265 | nucleoside phosphate binding | 9.09% (7/77) | 1.57 | 0.009105 | 0.032319 |
GO:0000166 | nucleotide binding | 9.09% (7/77) | 1.57 | 0.009105 | 0.032319 |
GO:0006974 | cellular response to DNA damage stimulus | 5.19% (4/77) | 2.28 | 0.009334 | 0.033005 |
GO:0071840 | cellular component organization or biogenesis | 19.48% (15/77) | 0.95 | 0.009537 | 0.033595 |
GO:0000278 | mitotic cell cycle | 3.9% (3/77) | 2.73 | 0.010516 | 0.036907 |
GO:0043138 | 3'-5' DNA helicase activity | 1.3% (1/77) | 6.49 | 0.011091 | 0.038346 |
GO:1900865 | chloroplast RNA modification | 1.3% (1/77) | 6.49 | 0.011091 | 0.038346 |
GO:0009011 | starch synthase activity | 1.3% (1/77) | 6.49 | 0.011091 | 0.038346 |
GO:0050896 | response to stimulus | 32.47% (25/77) | 0.64 | 0.011014 | 0.038509 |
GO:0043168 | anion binding | 7.79% (6/77) | 1.67 | 0.011499 | 0.039607 |
GO:0009150 | purine ribonucleotide metabolic process | 5.19% (4/77) | 2.18 | 0.011908 | 0.040864 |
GO:0009451 | RNA modification | 5.19% (4/77) | 2.14 | 0.012946 | 0.044264 |
GO:0010623 | programmed cell death involved in cell development | 1.3% (1/77) | 6.17 | 0.013845 | 0.044864 |
GO:0009558 | embryo sac cellularization | 1.3% (1/77) | 6.17 | 0.013845 | 0.044864 |
GO:0031109 | microtubule polymerization or depolymerization | 1.3% (1/77) | 6.17 | 0.013845 | 0.044864 |
GO:0016554 | cytidine to uridine editing | 1.3% (1/77) | 6.17 | 0.013845 | 0.044864 |
GO:0045995 | regulation of embryonic development | 1.3% (1/77) | 6.17 | 0.013845 | 0.044864 |
GO:0016841 | ammonia-lyase activity | 1.3% (1/77) | 6.17 | 0.013845 | 0.044864 |
GO:0061077 | chaperone-mediated protein folding | 1.3% (1/77) | 6.17 | 0.013845 | 0.044864 |
GO:0046785 | microtubule polymerization | 1.3% (1/77) | 6.17 | 0.013845 | 0.044864 |
GO:0043414 | macromolecule methylation | 6.49% (5/77) | 1.83 | 0.013414 | 0.045362 |
GO:0032259 | methylation | 6.49% (5/77) | 1.83 | 0.013414 | 0.045362 |
GO:0000280 | nuclear division | 2.6% (2/77) | 3.51 | 0.013391 | 0.045618 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 2.6% (2/77) | 3.49 | 0.013799 | 0.045995 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 2.6% (2/77) | 3.49 | 0.013799 | 0.045995 |
GO:0051567 | histone H3-K9 methylation | 3.9% (3/77) | 2.59 | 0.013743 | 0.046142 |
GO:0061647 | histone H3-K9 modification | 3.9% (3/77) | 2.59 | 0.013743 | 0.046142 |
GO:0000725 | recombinational repair | 2.6% (2/77) | 3.44 | 0.014629 | 0.047076 |
GO:0000724 | double-strand break repair via homologous recombination | 2.6% (2/77) | 3.44 | 0.014629 | 0.047076 |
GO:0005516 | calmodulin binding | 3.9% (3/77) | 2.55 | 0.014788 | 0.047424 |
GO:1901987 | regulation of cell cycle phase transition | 2.6% (2/77) | 3.4 | 0.015481 | 0.049305 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 2.6% (2/77) | 3.4 | 0.015481 | 0.049305 |
GO:0140513 | nuclear protein-containing complex | 3.9% (3/77) | 2.52 | 0.015655 | 0.049691 |